Literature DB >> 11761429

Classification of pituitary adenomas.

K Kovacs1, E Horvath, S Vidal.   

Abstract

This brief review summarizes various schemes which were introduced to classify pituitary tumors of adenohypophysial origin. Many different classifications were proposed. Pathologists prefer classifications based on the morphologic features of tumor cells. The gold standard is the light microscopic study of hematoxylin-eosin stained sections of formalin fixed and paraffin-embedded tissues. For correlation between hormone production, secretory activity and cytogenesis, immunohistochemical and transmission electron microscopic investigation is needed. We are convinced that in the future, molecular and genetic techniques will also be applied. We present here our five-tier scheme for classification of pituitary tumors which was accepted by the 'World Health Organization International Histological Classification of Tumours'. This classification takes into consideration the clinical and laboratory findings, imaging results, histologic, immunocytochemical and ultrastructural features of tumor cells. Despite several recent attempts to assess the growth rate, aggressiveness and invasiveness of pituitary tumors, more work is required to draw conclusions on their prognosis.

Entities:  

Mesh:

Year:  2001        PMID: 11761429     DOI: 10.1023/a:1012945129981

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  42 in total

Review 1.  The molecular pathogenesis of corticotroph tumors.

Authors:  P L Dahia; A B Grossman
Journal:  Endocr Rev       Date:  1999-04       Impact factor: 19.871

2.  Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  J Neurosurg       Date:  2000-08       Impact factor: 5.115

Review 3.  Current pathological classification of pituitary adenomas.

Authors:  W Saeger
Journal:  Acta Neurochir Suppl       Date:  1996

Review 4.  Nonfunctioning pituitary adenoma.

Authors:  M L Vance
Journal:  Curr Ther Endocrinol Metab       Date:  1997

Review 5.  Genetic basis of endocrine disease: pituitary tumor pathogenesis.

Authors:  I Shimon; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

Review 6.  Differential diagnosis of sellar masses.

Authors:  P U Freda; K D Post
Journal:  Endocrinol Metab Clin North Am       Date:  1999-03       Impact factor: 4.741

7.  Transdifferentiation of somatotrophs to thyrotrophs in the pituitary of patients with protracted primary hypothyroidism.

Authors:  S Vidal; E Horvath; K Kovacs; S M Cohen; R V Lloyd; B W Scheithauer
Journal:  Virchows Arch       Date:  2000-01       Impact factor: 4.064

8.  Clinically silent corticotroph tumors of the pituitary gland.

Authors:  B W Scheithauer; A J Jaap; E Horvath; K Kovacs; R V Lloyd; F B Meyer; E R Laws; W F Young
Journal:  Neurosurgery       Date:  2000-09       Impact factor: 4.654

Review 9.  Molecular pathogenesis of pituitary tumors.

Authors:  W E Farrell; R N Clayton
Journal:  Front Neuroendocrinol       Date:  2000-07       Impact factor: 8.606

Review 10.  Molecular basis of pituitary oncogenesis.

Authors:  M Tada; H Kobayashi; T Moriuchi
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

View more
  30 in total

Review 1.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  A neurosurgical assessment of the blood supply in the optochiasmatic system: a cadaveric-anatomic study.

Authors:  Duygu Baykal; Selcuk Yilmazlar; Recep Fedakar
Journal:  Anat Sci Int       Date:  2021-01-05       Impact factor: 1.741

3.  Relationship between postoperative volume of macroadenomas and clinical outcome after endoscopic trans-sphenoidal resection.

Authors:  Valeria Onofrj; Carina Vallejo; Paulo Puac; Carlos Zamora; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2018-08-09

4.  Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kolja Wawrowsky; Yuji Tani; Anat Ben-Shlomo; Vladimir Ljubimov; Adam Mamelak; Serguei Bannykh; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2012-10-09

5.  Spontaneous Pituitary Adenomas in Squirrel Monkeys (Saimiri sciureus).

Authors:  Gregory J Daggett; Jennifer S Wood; Sanjeev Gumber; Christopher J Pinelli
Journal:  Comp Med       Date:  2019-11-20       Impact factor: 0.982

6.  Expression of Eag1 K+ channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells.

Authors:  Margarita González del Pliego; Elsa Aguirre-Benítez; Karina Paisano-Cerón; Irene Valdovinos-Ramírez; Carlos Rangel-Morales; Verónica Rodríguez-Mata; Carmen Solano-Agama; Dolores Martín-Tapia; María Teresa de la Vega; Miguel Saldoval-Balanzario; Javier Camacho; María Eugenia Mendoza-Garrido
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

Review 7.  The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas.

Authors:  M Victoria Recouvreux; M Andrea Camilletti; Daniel B Rifkin; Graciela Díaz-Torga
Journal:  J Endocrinol       Date:  2015-12-23       Impact factor: 4.286

8.  Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas.

Authors:  R Cozzi; G Lasio; A Cardia; G Felisati; M Montini; R Attanasio
Journal:  J Endocrinol Invest       Date:  2009-04-29       Impact factor: 4.256

9.  Craniocaudal extension as an indication of surgical outcome in transsphenoidal surgery for pituitary adenomas.

Authors:  Ossama Hamid; Adel El Hakim; Hossam El Husseiny; Lobna El Fiky; Sherif Kamel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-27

Review 10.  Best Practice No 172: pituitary gland pathology.

Authors:  J W Ironside
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.